Regeneron: Driven by Science
For over 25 years, Regeneron's vision has been to build an innovative company that consistently brings new medicines to patients with serious diseases.
Regeneron Selected by Society for Science & the Public as New Sponsor of the Science Talent Search05/26/16
TARRYTOWN, N.Y. and WASHINGTON, May 26, 2016 /PRNewswire/ -- Society for Science & the Public (Society) today announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is the new title sponsor of the Science Talent Search. Selected through a competitive process that garnered interest from the n...
2016 Annual Meeting of Shareholders06/10/16 at 10:30 AM ET